home / stock / lgvn / lgvn news

LGVN News and Press, Longeveron Inc. From 04/08/22

Stock Information
Company Name: Longeveron Inc.
Stock Symbol: LGVN
Market: NASDAQ
Website: longeveron.com
Menu
LGVN LGVN Quote LGVN Short LGVN News LGVN Articles LGVN Message Board
Get LGVN Alerts

News, Short Squeeze, Breakout and More Instantly...
LGVN - Recession Fears are Creating a Golden Opportunity for Biotech Stocks

InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Moonshot Investor newsletter. To make sure you don’t miss any  of Tom’s potential 100x picks,  subscribe to his mailing list here . Rising Rates...
LGVN - Banco Bilbao Vizcaya Argentaria, Affirm Holdings, New Fortress Energy among premarket losers' pack

Senmiao Technology (AIHS) -16%. Anghami (ANGH) -11%. IMARA (IMRA) -10%. Celsion (CLSN) -9%. InflaRx (IFRX) -8%. Longeveron (LGVN) -8% after the company announced the appointment of Chris Min as its Chief Medical Officer. New Fortress Energy (NFE) -7%. Cano Health (CANO) -7%. GBS (GB...

LGVN - Longeveron ends record rally with appointment of new medical chief

After sharp gains last week, the clinical-stage biotech, Longeveron (LGVN -9.7%) closed lower for the second straight session on Tuesday after the company announced the appointment of Chris Min as its Chief Medical Officer (CMO). Longeveron (NASDAQ:LGVN) shares recorded the third-best weekly ...

LGVN - IMTE, MF and SABS among mid-day movers

Gainers: Sunshine Biopharma (SBFM) +132%. Dingdong Limited (DDL) +29%. System1 (SST) +27%. FG Financial Group (FGF) +25%. Missfresh (MF) +21%. BT Brands (BTBD) +20%. Longeveron (LGVN) +18%. Compass Therapeutics (CMPX) +18%. Allego (ALLG) +17%. Nam Tai Property (NTP) +15%. Losers: IMARA (IMRA)...
LGVN - Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical Officer

MIAMI, April 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and other specific life-threatening conditions, announced today the addition of K. Chris...

LGVN - VTNR, TKAT and ISIG among mid-day movers

Gainers: Protalix BioTherapeutics (PLX) +74%. Aterian (ATER) +62%. Dingdong Limited (DDL) +40%. Jumia Technologies (JMIA) +30%. Twitter (TWTR) +27%. Takung Art (TKAT) +24%. Gracell Biotechnologies (GRCL) +22%. Cognition Therapeutics (CGTX) +21%. Poema Global Holdings (PPGH) +20%. Biophytis (B...

LGVN - Protalix, Biophytis top healthcare gainers; while Curis, Longeveron lead losers' pack

Gainers: Protalix BioTherapeutics (PLX) +70%. Biophytis (BPTS) +21%. Clovis Oncology (CLVS) +13%. IN8bio (INAB) +13%. Acer Therapeutics (ACER) +12%. Losers: Curis (CRIS) -39%. Longeveron (LGVN) -15%. Bioventus (BVS) -14%. Clever Leaves (CLVR) -8%. NanoV...
LGVN - Stock Market Today: Dow Jones, S&P 500 Rebounds; GameStop (GME) Seeks Stock Split Amid Renewed Meme Stocks Hype

Stock Market Today Mid-Morning Updates On Friday, the Dow Jones Industrial Average is up by 60 points. This comes after Wall Street has ended its worst quarter since the first three months of 2020, which includes pandemic-era lows. U.S. listed Chinese stocks are up after China r...

LGVN - Best Penny Stocks of 2022? 3 to Watch During Morning Trading 

3 Penny Stocks to Watch on April 1st, 2022 With the end of another week of trading penny stocks here, there is a lot for investors to know. During early morning trading, we saw big movers like Longeveron Inc. ( NASDAQ: LGVN ) and Hycroft Mining Holding Corp. ( NASDAQ: HYMC ) bri...

LGVN - Longeveron extends gains on surging volume after publication of Alzheimer's data

Clinical-stage biotech, Longeveron (NASDAQ:LGVN) has extended its gains in the pre-market Friday as Wall Street continues to cheer the publication of results from a Phase 1 trial for its Alzheimer’s disease candidate Lomecel-B. Currently, Longeveron (LGVN) has added 13% with the t...
Previous 10 Next 10